Skip to main content
Current Molecular Medicine is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews on fundamental molecular mechanisms of disease pathogenesis, the development of molecular-diagnosis and/or novel approaches to rational treatment. The reviews should be of significant interest to basic researchers and clinical investigators in molecular medicine. Periodically the journal will invite guest editors to devote an issue on a basic research area that shows promise to advance our understanding of the molecular mechanism(s) of a disease or has potential for clinical applications.

Publisher: Bentham Science Publishers

More about this publication?
Volume 12, Number 8, 2012

Articles

The p53-Bak Apoptotic Signaling Axis Plays an Essential Role in Regulating Differentiation of the Ocular Lens
pp. 901-916(16)
Authors: Deng, M.; Chen, P.; Liu, F.; Fu, S.; Tang, H.; Fu, Y.; Xiong, Z.; Hui, S.; Ji, W.; Zhang, X.; Zhang, L.; Gong, L.; Hu, X.; Hu, W.; Sun, S.; Liu, J.; Xiao, L.; -B. Liu, W.; -M. Xiao, Y.; -J. Liu, S.; Liu, Y.; W.-C. Li, D.

Favourites:
ADD

The Tumor Suppressor p53 Regulates c-Maf and Prox-1 to Control Lens Differentiation
pp. 917-928(12)
Authors: -Y. Liu, F.; -C. Tang, X.; Deng, M.; Chen, P.; Ji, W.; Zhang, X.; Gong, L.; Woodward, Z.; Liu, J.; Zhang, L.; Sun, S.; -P. Liu, J.; Wu, K.; -X. Wu, M.; -L. Liu, X.; -B. Yu, M.; Liu, Y.; W.-C. Li, D.

Favourites:
ADD

p53 is an Important Regulator of CCL2 Gene Expression
pp. 929-943(15)
Authors: Tang, X.; Asano, M.; O'Reilly, A.; Farquhar, A.; Yang, Y.; Amar, S.

Favourites:
ADD

Open Access Multiple Target-Specific Molecular Imaging Agents Detect Liver Cancer in a Preclinical Model
pp. 944-951(8)
Authors: Ke, S.; Zhang, F.; Wang, W.; Qiu, X.; Lin, J.; G. Cameron, A.; Zou, C.; Gao, X.; Zou, C.; F. Zhu, V.; Li, M.

Favourites:
ADD

Andrographolide Inhibits Osteopontin Expression and Breast Tumor Growth Through Down Regulation of PI3 Kinase/Akt Signaling Pathway
pp. 952-966(15)
Authors: Kumar, S.; S. Patil, H.; Sharma, P.; Kumar, D.; Dasari, S.; G. Puranik, V.; V. Thulasiram, H.; C. Kundu, G.

Favourites:
ADD

Plumbagin Inhibits Breast Tumor Bone Metastasis and Osteolysis by Modulating the Tumor-Bone Microenvironment
pp. 967-981(15)
Authors: Li, Z.; Xiao, J.; Wu, X.; Li, W.; Yang, Z.; Xie, J.; Xu, L.; Cai, X.; Lin, Z.; Guo, W.; Luo, J.; Liu, M.

Favourites:
ADD

The PP2A-Aβ Gene is Regulated by Multiple Transcriptional Factors Including Ets-1, SP1/SP3, and RXRα /β
pp. 982-994(13)
Authors: Liu, J.; Ji, W.; Sun, S.; Zhang, L.; -G. Chen, H.; Mao, Y.; Liu, L.; Zhang, X.; Gong, L.; Deng, M.; Chen, L.; -J. Han, W.; -C. Chen, P.; -F. Hu, W.; Hu, X.; Liu, J.; Woodward, Z.; -B. Liu, W.; -M. Xiao, Y.; -P. Liang, S.; Liu, Y.; -J. Liu, S.; W.-C. Li, D.

Favourites:
ADD
Favourites:
ADD

Selenite Benefits Embryonic Stem Cells Therapy in Parkinson's Disease
pp. 1005-1014(10)
Authors: -P. Tian, L.; Zhang, S.; Xu, L.; Li, W.; Wang, Y.; -D. Chen, S.; -Q. Ding, J.

Favourites:
ADD

siRNA Silencing of Gene Expression in Trabecular Meshwork: RhoA siRNA Reduces IOP in Mice
pp. 1015-1027(13)
Authors: Liu, Q.; Wu, K.; Qiu, X.; Yang, Y.; Lin, X.; Yu, M.

Favourites:
ADD
Favourites:
ADD

Medaka piwi is Essential for Primordial Germ Cell Migration
pp. 1040-1049(10)
Authors: Li, M.; Hong, N.; Gui, J.; Hong, Y.

Favourites:
ADD

In Vitro Regulatory Effect of Epididymal Serpin CRES on Protease Activity of Proprotein Convertase PC4/PCSK4
pp. 1050-1067(18)
Authors: Mishra, P.; Qiu, Q.; Gruslin, A.; Hidaka, Y.; Mbikay, M.; Basak, A.

Favourites:
ADD

Targeting the Tumor Proteasome as a Mechanism to Control the Synthesis and Bioactivity of Matrix Macromolecules
pp. 1068-1082(15)
Authors: S. Skandalis, S.; J. Aletras, A.; Gialeli, C.; D. Theocharis, A.; Afratis, N.; N. Tzanakakis, G.; K. Karamanos, N.

Favourites:
ADD

Structure, Function and Control of Complement C5 and its Proteolytic Fragments
pp. 1083-1097(15)
Authors: S. Laursen, N.; Magnani, F.; H. Gottfredsen, R.; V. Petersen, S.; R. Andersen, G.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content